India procures monoclonal antibodies from Australia to battle deadly Nipah virus

Nipah virus: Use of monoclonal antibody allowed, India reaches out to Australia for doses

Six persons have tested positive for the virus in the current outbreak in Kerala’s Kozhikode district and two have died.

Nipah virus: Australia's antibody doses sought, ICMR to work on vaccine

Nipah virus: Kerala reported sixth Nipah virus case while India has sought antibody treatment from Australia.

India procures monoclonal antibodies from Australia to battle deadly Nipah virus

India has taken a significant step in its preparedness to combat the dangerous Nipah virus by procuring an additional 20 doses of monoclonal antibodies from Australia.  On Friday, Indian Council of Medical Research (ICMR), Director General Rajeev Bahl said: "We got some doses of monoclonal antibody from Australia in 2018. Currently, the doses are available for only 10 patients."

India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR DG

India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR DG India has reached out to Australia for procuring 20 more doses of monoclonal antibody for the treatment of Nipah virus infection amid cases being reported from Kerala, ICMR DG Rajeev Bahl said on Friday.With repeated instances of Nipah outbreaks being reported from the southern state and the mortality rate very high compared to Covid, Bahl said tha…

India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR chief

ICMR procuring 20 more doses of monoclonal antibody to treat Nipah virus in India; globally, 14 patients have survived after being administered the medicine. Mortality rate of Nipah virus is 40-70%, compared to 2-3% of COVID-19. Kerala govt, doctors & families to decide if antibody should be used. #ICMR #NipahVirus #Kerala #MonoclonalAntibody #COVID19

Nipah virus: India to source 20 more doses of monoclonal antibody from Australia for treatment

India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR)